HORIZON PHARMA PLC's ticker is HZNPXXXX and the CUSIP is G4617B105. A total of 2 filers reported holding HORIZON PHARMA PLC in Q3 2023. The put-call ratio across all filers is - and the average weighting 5.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $3,186,000 | – | 120,562 | – | 1.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Broadfin Capital, LLC | 5,959,819 | $96,430,000 | 10.71% |
Consonance Capital Management LP | 5,793,903 | $93,745,000 | 10.30% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 8,956,988 | $144,924,000 | 5.96% |
JW Asset Management, LLC | 507,075 | $8,205,000 | 5.46% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 6,682,618 | $108,125,000 | 5.23% |
NEXTHERA CAPITAL LP | 500,000 | $8,090,000 | 4.74% |
Lion Point Capital, LP | 1,164,414 | $18,840,000 | 4.58% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 4,503,900 | $72,873,000 | 3.52% |
ARMISTICE CAPITAL, LLC | 650,000 | $10,517,000 | 2.49% |
SCOPIA CAPITAL MANAGEMENT LP | 8,081,650 | $130,761,000 | 2.48% |